Vidara Therapeutics

Vidara Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing, marketing, and distributing pharmaceutical products, particularly those addressing orphan disease states and critical care settings. Founded in 2011 and based in Alpharetta, Georgia, the company specializes in products such as Actimmune, a bioengineered form of interferon gamma-1b. Actimmune is utilized to reduce the frequency and severity of serious infections in patients with chronic granulomatous disease and to delay disease progression in individuals with severe malignant osteopetrosis. Vidara Therapeutics aims to create value through strategic product acquisitions, effective marketing, and comprehensive life cycle management.